HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >

STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization

Files in This Item:
WoS_81357_matsuda.pdf1.75 MBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/72029

Title: STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization
Authors: Kitai, Yuichi Browse this author →KAKEN DB
Iwakami, Masashi Browse this author
Saitoh, Kodai Browse this author
Togi, Sumihito Browse this author
Isayama, Serina Browse this author
Sekine, Yuichi Browse this author
Muromoto, Ryuta Browse this author →KAKEN DB
Kashiwakura, Jun-ichi Browse this author
Yoshimura, Akihiko Browse this author
Oritani, Kenji Browse this author
Matsuda, Tadashi Browse this author →KAKEN DB
Keywords: adaptor protein
prostate cancer
protein degradation
signal transduction
STAT3
c-CBL
Issue Date: 24-Nov-2017
Publisher: American Society for Biochemistry and Molecular Biology (ASBMB)
Journal Title: Journal of Biological Chemistry (JBC)
Volume: 292
Issue: 47
Start Page: 19392
End Page: 19399
Publisher DOI: 10.1074/jbc.M117.802884
Abstract: Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various intracellular signaling pathways and promotes tumorigenesis in melanoma and breast cancer cells. However, the contribution of STAP-2 to the behavior of other types of cancer cells is unclear. Here, we show that STAP-2 promotes tumorigenesis of prostate cancer cells through up-regulation of EGF receptor (EGFR) signaling. Tumor growth of a prostate cancer cell line, DU145, was strongly decreased by STAP-2 knockdown. EGF-induced gene expression and phosphorylation of AKT, ERK, and STAT3 were significantly decreased in STAP-2-knockdown DU145 cells. Mechanistically, we found that STAP-2 interacted with EGFR and enhanced its stability by inhibiting c-CBL-mediated EGFR ubiquitination. Our results indicate that STAP-2 promotes prostate cancer progression via facilitating EGFR activation.
Rights: This research was originally published in J. Biol. Chem. Kitai,Yuichi et al. STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization. J. Biol. Chem. 2017; 292(47):19392-19399. © the American Society for Biochemistry and Molecular Biology.
Type: article
URI: http://hdl.handle.net/2115/72029
Appears in Collections:薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 松田 正

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University